“Haemophilus Influenzae Type B Polyribosylribitol Phosphate-Tetanus (Hib PRP-T) Vaccine Safety, Phase I Study”. International Journal of Integrated Health Sciences, vol. 3, no. 2, Sept. 2015, pp. 55-59, https://doi.org/10.15850/ijihs.v3n2.584.